Pura Vida Investments’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

Pura Vida Investments’s Portfolio KRSA Stock Details KRSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-5,546	Closed	-$862K	–	228
2022 Q1	$862K	Buy	5,546 +34	+0.6%	+$819	0.03%	188
2021 Q4	$1.33M	Buy	5,512 +2,495	+83%	+$118K	0.05%	163
2021 Q3	$1.3M	Sell	3,017 -608	-17%	-$39.8K	0.04%	209
2021 Q2	$1.98M	Buy	+3,625	New	+$227K	0.06%	160

Other funds holding KRSA

SPC

Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TFS

TrustCore Financial Services Brentwood, Tennessee $1.14B AUM 13.32% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return

Pura Vida Investments's KRSA Position: Q2 2022 in Review

Pura Vida Investments sold out of Korsana Biosciences, Inc. Common Stock (KRSA) in Q2 2022, closing a stake of 5,546 shares — an estimated $862K sold.

Pura Vida Investments first reported a position in KRSA in Q2 2021 and held it in 4 quarters. The position peaked at $1.98M in Q2 2021. 36 funds tracked by Wall St. Rank hold KRSA as of Q2 2022.

Pura Vida Investments reported no remaining Korsana Biosciences, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Pura Vida Investments sold 5,546 Korsana Biosciences, Inc. Common Stock shares in Q2 2022, an estimated $862K.
Pura Vida Investments first reported a position in Korsana Biosciences, Inc. Common Stock in Q2 2021 and held it in 4 quarters.
Pura Vida Investments's Korsana Biosciences, Inc. Common Stock position peaked at $1.98M in Q2 2021.
36 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q2 2022.

Based on Pura Vida Investments's 13F filing for Q2 2022, filed 15 Aug 2022.